Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo

Cancer Immunology, Immunotherapy

Volumn 61, Issue 11, 2012, Pages 1917-1927

  Yan, Xiaocai ^a   Doffek, Kara ^a   Yin, Chaobo ^b   Krein, Michael ^b   Phillips, Michael ^a   Sugg, Sonia L ^b   Johnson, Bryon ^a   Shilyansky, Joel ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Annexin V; Neuroblastoma; Phosphatidylserine; T cell; Tumor; Tumor immunity

Indexed keywords

CANCER VACCINE; GAMMA INTERFERON; LIPOCORTIN 5 SECRETING CELL VACCINE; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER IMMUNIZATION; CANCER INHIBITION; CELL SURFACE; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; GENETIC ENGINEERING; GENETIC TRANSFECTION; IMMUNOCOMPETENCE; IMMUNOPHARMACOLOGY; IN VIVO STUDY; INOCULATION; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN SECRETION; SPLEEN CELL; T CELL DEPLETION; TUMOR IMMUNITY; WILD TYPE;

ANIMALS; ANNEXIN A5; CELL SURVIVAL; IMMUNOTHERAPY; INTERFERON-GAMMA; MICE; MICE, INBRED STRAINS; NEUROBLASTOMA; PHOSPHATIDYLSERINES; SELF TOLERANCE; SPLEEN; T-LYMPHOCYTES;

EID: 84870984151     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1250-4     Document Type: Article

References (44)

1. Van Mierlo GJ, Boonman ZF, Dumortier HM, den Boer AT, Fransen MF, Nouta J, van der Voort EI, Offringa R, Toes RE, Melief CJ (2004) Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8 ? CTL to cause tumor eradication. J Immunol 173(11):6753-6759
2. Ghiringhelli F, Apetoh L, Housseau F, Kroemer G, Zitvogel L (2007) Links between innate and cognate tumor immunity. Curr Opin Immunol 19(2):224-231
3. Steitz J, Bruck J, Lenz J, Knop J, Tuting T (2001) Depletion of CD25(?) CD4(?) T cells and treatment with tyrosinase-related protein 2-Transduced dendritic cells enhance the interferon alphainduced, CD8(?) T-cell-dependent immune defense of B16 melanoma. Cancer Res 61(24):8643-8646
4. Handel-Fernandez ME, Cheng X, Herbert LM, Lopez DM (1997) Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice. J Immunol 158(1):280-286
5. Barth RJ Jr, Mule JJ, Spiess PJ, Rosenberg SA (1991) Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8 ? tumor-infiltrating lymphocytes. J Exp Med 173(3):647-658
6. Matsui S, Ahlers JD, Vortmeyer AO, Terabe M, Tsukui T, Carbone DP, Liotta LA, Berzofsky JA (1999) A model for CD8 ? CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL. J Immunol 163(1):184-193
7. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD (1998) Demonstration of an interferon gammadependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 95(13):7556-7561
8. Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD (2005) A critical function for type I interferons in cancer immunoediting. Nat Immunol 6(7):722-729
9. Rousseau RF, Brenner MK (2005) Vaccine therapies for pediatric malignancies. Cancer J 11(4):331-339
10. Smyth MJ, Godfrey DI, Trapani JA (2001) A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2(4):293-299
11. Rabinovich GA, Gabrilovich D, Sotomayor EM (2007) Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25:267-296
12. Kim S, Elkon KB, Ma X (2004) Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21(5):643-653
13. Hoffmann PR, Kench JA, Vondracek A, Kruk E, Daleke DL, Jordan M, Marrack P, Henson PM, Fadok VA (2005) Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol 174(3):1393-1404
14. Chen X, Doffek K, Sugg SL, Shilyansky J (2004) Phosphatidylserine regulates the maturation of human dendritic cells. J Immunol 173(5):2985-2994
15. Bondanza A, Zimmermann VS, Rovere-Querini P, Turnay J, Dumitriu IE, Stach CM, Voll RE, Gaipl US, Bertling W, Poschl E, Kalden JR, Manfredi AA, Herrmann M (2004) Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med 200(9):1157-1165
16. Williamson P, Schlegel RA (2002) Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim Biophys Acta 1585(2-3):53-63
17. Asano K, Miwa M, Miwa K, Hanayama R, Nagase H, Nagata S, Tanaka M (2004) Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J Exp Med 200(4):459-467
18. Henson PM, Bratton DL, Fadok VA (2001) The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 2(8):627-633
19. Gaipl US, Beyer TD, Baumann I, Voll RE, Stach CM, Heyder P, Kalden JR, Manfredi A, Herrmann M (2003) Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal-implications for antiphospholipid syndrome and systemic lupus erythematosus. Immunobiology 207(1):73-81
20. Pohl A, Lage H, Muller P, Pomorski T, Herrmann A (2002) Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line. Biochem J 365(Pt 1):259-268
21. Woehlecke H, Pohl A, Alder-Baerens N, Lage H, Herrmann A (2003) Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2). Biochem J 376(2):489-495
22. Elliott JI, Surprenant A, Marelli-Berg FM, Cooper JC, Cassady-Cain RL, Wooding C, Linton K, Alexander DR, Higgins CF (2005) Membrane phosphatidylserine distribution as a nonapoptotic signalling mechanism in lymphocytes. Nat Cell Biol 7(8):808-816
23. Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, Chimini G (2000) ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2(7):399-406
24. Stach CM, Turnay X, Voll RE, Kern PM, Kolowos W, Beyer TD, Kalden JR, Herrmann M (2000) Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice. Cell Death Differ 7(10):911-915
25. Yan X, Johnson BD, Orentas RJ (2004) Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo. Immunology 112(1):105-116
26. Jing W, Orentas RJ, Johnson BD (2007) Induction of immunity to neuroblastoma early after syngeneic hematopoietic stem cell transplantation using a novel mouse tumor vaccine. Biol Blood Marrow Transplant 13(3):277-292
27. Johnson BD, Yan X, Schauer DW, Orentas RJ (2003) Dual expression of CD80 and CD86 produces a tumor vaccine superior to single expression of either molecule. Cell Immunol 222(1):15-26
28. He J, Luster TA, Thorpe PE (2007) Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids. Clin Cancer Res 13(17):5211-5218
29. Wang RF, Miyahara Y, Wang HY (2008) Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene 27(2):181-189
30. Chen X, Doffek K, Sugg SL, Shilyansky J (2003) Neuroblastoma cells inhibit the immunostimulatory function of dendritic cells. J Pediatr Surg 38(6):901-905
31. Shurin GV, Lotze MT, Barksdale EM (2000) Neuroblastoma inhibits dendritic cell differentiation and function. Curr Surg 57(6):637
32. Horna P, Sotomayor EM (2007) Cellular and molecular mechanisms of tumor-induced T-cell tolerance. Curr Cancer Drug Targets 7(1):41-53
33. Zhou G, Levitsky HI (2007) Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance. J Immunol 178(4):2155-2162
34. Kim R, Emi M, Tanabe K (2005) Cancer cell immune escape and tumor progression by exploitation of anti-inflammatory and proinflammatory responses. Cancer Biol Ther 4(9):924-933
35. Johnson BD, Gershan JA, Natalia N, Zujewski H, Weber JJ, Yan X, Orentas RJ (2005) Neuroblastoma cells transiently transfected to simultaneously express the co-stimulatory molecules CD54, CD80, CD86, and CD137L generate antitumor immunity in mice. J Immunother 28(5):449-460
36. Kenis H, Hofstra L, Reutelingsperger CP (2007) Annexin A5: shifting from a diagnostic towards a therapeutic realm. Cell Mol Life Sci 64(22):2859-2862
37. Ran S, Downes A, Thorpe PE (2002) Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 62(21):6132-6140
38. Calderon C, Huang ZH, Gage DA, Sotomayor EM, Lopez DM (1994) Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidylserine. J Exp Med 180(3):945-958
39. Fonseca C, Dranoff G (2008) Capitalizing on the immunogenicity of dying tumor cells. Clin Cancer Res 14(6):1603-1608
40. Beck AW, Luster TA, Miller AF, Holloway SE, Conner CR, Barnett CC, Thorpe PE, Fleming JB, Brekken RA (2006) Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice. Int J Cancer 118(10):2639-2643
41. He J, Yin Y, Luster TA, Watkins L, Thorpe PE (2009) Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clin Cancer Res 15(22):6871-6880
42. Huynh ML, Fadok VA, Henson PM (2002) Phosphatidylserinedependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109(1):41-50
43. Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH (2010) TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 235(1):172-189
44. Kobayashi N, Karisola P, Pena-Cruz V, Dorfman DM, Jinushi M, Umetsu SE, Butte MJ, Nagumo H, Chernova I, Zhu B, Sharpe AH, Ito S, Dranoff G, Kaplan GG, Casasnovas JM, Umetsu DT, Dekruyff RH, Freeman GJ (2007) TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27(6):927-940